F.Y.I.

APG to discuss synthetic biology and personalised healthcare

March 1, 2012 2:49

The Account Planning Group will discuss the world of synthetic biology and its impact on personalised healthcare and reproduction with speaker Romain Bonjean, co-founder & CEO of genetics firm Lumigenix

The announcement:

The Account Planning Group is venturing into the world of synthetic biology for its next event, looking at the critical impact this field is having on personalised healthcare and reproduction.

The APG has secured speaker Romain Bonjean, Co-Founder & CEO of genetics firm Lumigenix, to talk modern genetics, genomics and bioinformatics for its Ideas exchange, held March 15 in Sydney.

Be a member to keep reading

Join Mumbrella Pro to access the Mumbrella archive and read our premium analysis of everything under the media and marketing umbrella.

Become a member

Topics

APG